• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样寡聚体加剧了神经tau 病小鼠模型中的 tau 病理。

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy.

机构信息

Department of Molecular Pharmacology and Physiology, USF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, FL 33613, USA.

出版信息

Neurodegener Dis. 2013;11(4):165-81. doi: 10.1159/000337230. Epub 2012 Jul 10.

DOI:10.1159/000337230
PMID:22796753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3739054/
Abstract

BACKGROUND

We aimed to investigate the influence of oligomeric forms of β-amyloid (Aβ) and the influence of the duration of exposure on the development of tau phosphorylation.

METHODS

Aβ oligomers were injected intracranially either acutely into 5-month-old rTg4510 mice and tissue was collected 3 days later, or chronically into 3-month-old mice and tissue was collected 2 months later. Several forms of phosphorylated tau (p-tau), GSK3 (glycogen synthase kinase-3) and microglial and astrocyte activation were measured.

RESULTS

Acute injections of Aβ oligomers had no effect on p-tau epitopes but did result in elevation of phosphorylated/activated GSK3 (pGSK3). Chronic infusion of Aβ oligomers into the right hippocampus resulted in 3- to 4-fold elevations in several p-tau isoforms with no changes in total tau levels. A significant elevation in pGSK3 accompanied these changes. Microglial staining with CD68 paralleled the increase in tau phosphorylation, however, CD45 staining was unaffected by Aβ. Control experiments revealed that the infusion of Aβ from the minipumps was largely complete by 10 days after implantation. Thus, the elevation in p-tau 2 months after implantation implies that the changes are quite persistent.

CONCLUSION

Soluble Aβ(1-42) oligomers have long-lasting effects on tau phosphorylation in the rTg4510 model, possibly due to elevations in GSK3. These data suggest that even brief elevations in Aβ production, may have enduring impact on the risk for tauopathy.

摘要

背景

我们旨在研究β-淀粉样蛋白(Aβ)寡聚体的影响,以及暴露时间对tau 磷酸化发展的影响。

方法

将 Aβ 寡聚体急性或慢性注射到 rTg4510 小鼠的大脑中,急性注射组在 3 天后收集组织,慢性注射组在 2 个月后收集组织。测量几种磷酸化 tau(p-tau)、GSK3(糖原合酶激酶-3)以及小胶质细胞和星形胶质细胞的激活情况。

结果

急性注射 Aβ 寡聚体对 p-tau 表位没有影响,但导致磷酸化/激活的 GSK3(pGSK3)升高。慢性将 Aβ 寡聚体注入右侧海马体导致几种 p-tau 同工型的 3 至 4 倍升高,而总 tau 水平没有变化。pGSK3 的显著升高伴随着这些变化。CD68 染色的小胶质细胞与 tau 磷酸化的增加平行,但 CD45 染色不受 Aβ 的影响。对照实验表明,植入后 10 天内,微型泵中的 Aβ 输注基本完成。因此,植入后 2 个月 p-tau 的升高意味着这些变化非常持久。

结论

可溶性 Aβ(1-42)寡聚体在 rTg4510 模型中对 tau 磷酸化具有持久的影响,可能是由于 GSK3 的升高。这些数据表明,即使是短暂的 Aβ 产生升高,也可能对 tau 病的风险产生持久的影响。

相似文献

1
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy.淀粉样寡聚体加剧了神经tau 病小鼠模型中的 tau 病理。
Neurodegener Dis. 2013;11(4):165-81. doi: 10.1159/000337230. Epub 2012 Jul 10.
2
Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.针对β-淀粉样蛋白的抗体在体内和体外均可减少β-淀粉样蛋白寡聚体、糖原合酶激酶-3β激活及tau蛋白磷酸化。
J Neurosci Res. 2006 Feb 15;83(3):374-84. doi: 10.1002/jnr.20734.
3
Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau.海马淀粉样前体蛋白和铁的持续升高是β-淀粉样蛋白毒性的特征,并由tau蛋白介导。
Neurotherapeutics. 2015 Oct;12(4):862-73. doi: 10.1007/s13311-015-0378-2.
4
Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.利福平是一种针对淀粉样β和tau 寡聚物的候选预防药物。
Brain. 2016 May;139(Pt 5):1568-86. doi: 10.1093/brain/aww042. Epub 2016 Mar 28.
5
Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.过度表达 APP 和三重复 Tau 的转基因小鼠中海马体的易损性增加。
J Alzheimers Dis. 2018;61(3):1201-1219. doi: 10.3233/JAD-170388.
6
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.LPS 诱导的炎症会加重 rTg4510 小鼠中的磷酸化 tau 病理。
J Neuroinflammation. 2010 Sep 16;7:56. doi: 10.1186/1742-2094-7-56.
7
CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.脑内 CCL2 的过表达促进神经胶质细胞激活,并加速tau 病模型小鼠的 Tau 病理学。
Front Immunol. 2020 May 20;11:997. doi: 10.3389/fimmu.2020.00997. eCollection 2020.
8
Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.积雪草对β-淀粉样蛋白(Aβ)诱导的小胶质细胞介导的神经炎症具有神经保护作用,并减轻 SH-SY5Y 细胞中 tau 的过度磷酸化。
J Ethnopharmacol. 2018 May 10;217:187-194. doi: 10.1016/j.jep.2018.02.025. Epub 2018 Feb 17.
9
The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic.tau 蛋白与 β-淀粉样蛋白的相互作用:虽然 tau 病的传播比淀粉样蛋白病更广泛,但这两个过程的致病性几乎是相等的。
Cell Mol Neurobiol. 2021 Aug;41(6):1339-1354. doi: 10.1007/s10571-020-00906-2. Epub 2020 Jul 22.
10
Increased tauopathy drives microglia-mediated clearance of beta-amyloid.tau 病增多会促使小胶质细胞介导β-淀粉样蛋白清除。
Acta Neuropathol Commun. 2016 Jun 23;4(1):63. doi: 10.1186/s40478-016-0336-1.

引用本文的文献

1
Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies.解析Tau蛋白:对神经炎症、病理生理学及新兴免疫疗法的分子见解
Curr Issues Mol Biol. 2023 Nov 2;45(11):8816-8839. doi: 10.3390/cimb45110553.
2
Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer's Disease for Research and Drug Development.合成的、细胞来源的、脑源性的和重组的β-淀粉样蛋白:用于研究和药物开发的阿尔茨海默病建模。
Int J Mol Sci. 2022 Nov 30;23(23):15036. doi: 10.3390/ijms232315036.
3
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals.阿尔茨海默病患者脑脊液 A beta 1-40 肽增加,与对照个体中的磷酸化 tau 高度相关。
Alzheimers Res Ther. 2020 Oct 2;12(1):123. doi: 10.1186/s13195-020-00696-1.
4
Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.化学遗传方法减弱内侧嗅皮层神经元活性可减少海马区 Aβ 和 tau 病理学改变。
PLoS Biol. 2020 Aug 21;18(8):e3000851. doi: 10.1371/journal.pbio.3000851. eCollection 2020 Aug.
5
Lipopolysaccharide exposure during late embryogenesis triggers and drives Alzheimer-like behavioral and neuropathological changes in CD-1 mice.脂多糖在胚胎晚期暴露会引发和驱动 CD-1 小鼠出现阿尔茨海默病样的行为和神经病理学变化。
Brain Behav. 2020 Mar;10(3):e01546. doi: 10.1002/brb3.1546. Epub 2020 Jan 30.
6
Amyloid-beta induced retrograde axonal degeneration in a mouse tauopathy model.淀粉样β诱导的小鼠 tau 病模型中的逆行轴突变性。
Neuroimage. 2019 Apr 1;189:180-191. doi: 10.1016/j.neuroimage.2019.01.007. Epub 2019 Jan 7.
7
Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons.生理浓度的 Aβ 在 iPSC 来源的人类神经元中产生更类似阿尔茨海默病表型的生物模拟。
ACS Chem Neurosci. 2018 Jul 18;9(7):1693-1701. doi: 10.1021/acschemneuro.8b00067. Epub 2018 May 22.
8
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.阿尔茨海默病和tau蛋白病中菌株特异性免疫疗法的前景。
NPJ Vaccines. 2018 Feb 27;3:9. doi: 10.1038/s41541-018-0046-8. eCollection 2018.
9
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.mTOR 在唐氏综合征中的作用:在 Aβ 和 tau 神经病理学及向阿尔茨海默病样痴呆的转变中的作用。
Free Radic Biol Med. 2018 Jan;114:94-101. doi: 10.1016/j.freeradbiomed.2017.08.009. Epub 2017 Aug 12.
10
Inflammatory insult during pregnancy accelerates age-related behavioral and neurobiochemical changes in CD-1 mice.孕期的炎症刺激会加速CD-1小鼠与年龄相关的行为和神经生化变化。
Age (Dordr). 2016 Jun;38(3):59. doi: 10.1007/s11357-016-9920-3. Epub 2016 May 19.

本文引用的文献

1
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.阿尔茨海默病病理过程的阶段:年龄类别为 1 至 100 岁。
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379.
2
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ.一种针对合成 Aβ 二聚体组装物的单克隆抗体可中和脑源性破坏突触可塑性的 Aβ。
J Neurochem. 2011 Oct;119(1):189-201. doi: 10.1111/j.1471-4159.2011.07389.x. Epub 2011 Aug 22.
3
Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein.阿尔茨海默病脑源性淀粉样蛋白-β在体内介导的 LTP 抑制可被针对细胞朊病毒蛋白的免疫靶向所预防。
J Neurosci. 2011 May 18;31(20):7259-63. doi: 10.1523/JNEUROSCI.6500-10.2011.
4
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.淀粉样蛋白-β/Fyn 诱导的突触、网络和认知障碍依赖于阿尔茨海默病多种小鼠模型中的 tau 水平。
J Neurosci. 2011 Jan 12;31(2):700-11. doi: 10.1523/JNEUROSCI.4152-10.2011.
5
Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.tau 蛋白向树突棘的定位错误介导了突触功能障碍,而与神经退行性变无关。
Neuron. 2010 Dec 22;68(6):1067-81. doi: 10.1016/j.neuron.2010.11.030.
6
Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain.脑室内增强输送和全身甘露醇给药增加了 AAV 载体 5、8 和 9 的基因产物分布,并增加了成年小鼠大脑中的基因产物。
J Neurosci Methods. 2010 Dec 15;194(1):144-53. doi: 10.1016/j.jneumeth.2010.10.010. Epub 2010 Oct 15.
7
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.LPS 诱导的炎症会加重 rTg4510 小鼠中的磷酸化 tau 病理。
J Neuroinflammation. 2010 Sep 16;7:56. doi: 10.1186/1742-2094-7-56.
8
Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.Abeta 寡聚体导致局部 Ca(2+) 升高、内源性 Tau 错误分拣到树突、Tau 磷酸化以及微管和棘突的破坏。
J Neurosci. 2010 Sep 8;30(36):11938-50. doi: 10.1523/JNEUROSCI.2357-10.2010.
9
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology.无症状 MAPT 突变携带者中的 MRS:tau 介导的病理学的潜在生物标志物。
Neurology. 2010 Aug 31;75(9):771-8. doi: 10.1212/WNL.0b013e3181f073c7.
10
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.tau 的树突功能介导阿尔茨海默病小鼠模型中的淀粉样β毒性。
Cell. 2010 Aug 6;142(3):387-97. doi: 10.1016/j.cell.2010.06.036. Epub 2010 Jul 22.